These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3147592)

  • 1. Particulate matter contamination associated with automated compounding TPN solutions.
    Quercia RA
    Am J Hosp Pharm; 1988 Nov; 45(11):2324-5. PubMed ID: 3147592
    [No Abstract]   [Full Text] [Related]  

  • 2. Particulate evaluation of parenteral nutrition solutions by electronic particle counting and scanning electron microscopy.
    Akers MJ; Schrank GD; Russell S
    Am J Hosp Pharm; 1981 Sep; 38(9):1304-7. PubMed ID: 6792911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of patient related parenteral nutrition solutions].
    Schroeder W
    Beitr Infusionther Klin Ernahr; 1986; 14():79-81. PubMed ID: 3096304
    [No Abstract]   [Full Text] [Related]  

  • 4. Extent of trace-element contamination from simulated compounding of total parenteral nutrient solutions.
    Pluhator-Murton MM; Fedorak RN; Audette RJ; Marriage BJ; Yatscoff RW
    Am J Health Syst Pharm; 1996 Oct; 53(19):2299-303. PubMed ID: 8893068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrogen contamination of total parenteral nutrition solutions: a case report.
    Stansfield SA; Jones EL
    Can J Hosp Pharm; 1983; 36(1):21, 28. PubMed ID: 10310172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AV program available on plastic bag system preparation of TPN solutions.
    Am J Hosp Pharm; 1979 Feb; 36(2):263. PubMed ID: 84531
    [No Abstract]   [Full Text] [Related]  

  • 7. More efficient system for preparing total parenteral nutrient solutions.
    Condella F; Baptista RJ; Griffin RE
    Am J Hosp Pharm; 1983 Dec; 40(12):2146-9. PubMed ID: 6419587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth of bacteria and fungi in parenteral nutrition solutions containing albumin.
    Mirtallo JM; Caryer K; Schneider PJ; Ayers L; Fabri PJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1907-10. PubMed ID: 6798862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good manufacturing in All in One compounding.
    Delanghe M
    Nutrition; 1989; 5(5):352-4. PubMed ID: 2520326
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical implications of preserving TPN solutions with sodium acetate.
    Hazlet TK; Vrabel RB
    Am J Hosp Pharm; 1980 Nov; 37(11):1480-2. PubMed ID: 6782867
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of the handheld programmable calculator in the preparation of TPN solutions.
    DiDonato LJ
    Hosp Pharm; 1983 Oct; 18(10):526-8, 531-3. PubMed ID: 10310318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particulate-matter content of D5/NS for injection: manufacturer difference and conformance with USP limits.
    Smith JK; Baumann RR; Gunning WT; Annancy L; Alexander KS
    J Parenter Sci Technol; 1988; 42(6):180-6. PubMed ID: 3273493
    [No Abstract]   [Full Text] [Related]  

  • 13. [The origin of particulate contamination in injectable solutions].
    Lambert G; Moës A
    J Pharm Belg; 1972; 27(4):402-16. PubMed ID: 4681074
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of a 2-liter plastic container for parenteral nutrient solutions.
    Thorn DB; Tanner DJ
    Am J Hosp Pharm; 1984 Apr; 41(4):680-5. PubMed ID: 6426298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Control of the biological contamination index in total parenteral nutrition (TPN) preparations].
    Llor Ferrández B; Hernández Sansalvador M; Gómez-Juárez F
    Nutr Hosp; 1993 Feb; 8(2):115-9. PubMed ID: 8466994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial contamination of parenteral and enteral nutrition solutions.
    Allwood MC
    Acta Chir Scand Suppl; 1981; 507():383-7. PubMed ID: 6797199
    [No Abstract]   [Full Text] [Related]  

  • 17. Amino acid stability and microbial growth in total parenteral nutrient solutions.
    Parr MD; Bertch KE; Rapp RP
    Am J Hosp Pharm; 1985 Dec; 42(12):2688-91. PubMed ID: 3936355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of particulate contamination from ophthalmic solutions for intraocular surgery.
    Jaffe NS
    Bull Parenter Drug Assoc; 1970; 24(5):218-25. PubMed ID: 5471332
    [No Abstract]   [Full Text] [Related]  

  • 19. Counting of particulate matter in parenteral solutions. I. Survey of the literature.
    Lines RW
    Bull Parenter Drug Assoc; 1967; 21(4):113-7. PubMed ID: 4859718
    [No Abstract]   [Full Text] [Related]  

  • 20. Forms used in pharmacy management of the TPN patient.
    DiTrapano VC
    Hosp Pharm; 1979 Mar; 14(3):143, 146, 153. PubMed ID: 10308845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.